Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by amorakon Aug 31, 2011 12:11pm
181 Views
Post# 18998198

RE: New Direction

RE: New DirectionVikink, man, yo're so far behind you think you're in the lead. LOL
.
We've talked about the preventive use of the NexVas drugs since the beginning, years ago. Are you really so short in your understanding of this that you could actually think that a drug that cures or effectively treats CVD would not also be used to prevent it?I don't think you understand the science involved with RVX208! (That's predictable about you, Vikink.)
.
What do you think the medical profession would do, wait around for people to get full-blown heart disease before they started raising their ApoA1 levels?
.
Don't you remember the discussion we had here (ad nauseum) about the preventive, chronic and acute care indications for this program?
.
Why do you think this is such a great investment? It's only partly the odds of success. It's actually the monstrous size of the markets for this if it's successful! The reason for the bet - the reward is so high relative to the risk!!
.
You gotta go do some homework on this, Vikink. You're embarrassing yourself here.
.
Funny though...
Bullboard Posts